In this study, we showed that the KF4 anti-CELA1 antibody and purified human AAT were similarly effective at preventing emphysema in a mouse model of AAT-deficient emphysema and that KF4 has the potential for renal and hepatic toxicity. This evidence concerns the gene SERPINA1 and pulmonary emphysema.